{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:08:22Z","timestamp":1793113702943,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.schres.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T07:08:08Z","timestamp":1612595288000},"page":"417-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study"],"prefix":"10.1016","volume":"228","author":[{"given":"Jihoon","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.01.006_bb0005","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0025-7125(16)30754-4","article-title":"Suicide: a guide to risk factors, assessment, and treatment of suicidal patients","volume":"72","author":"Blumenthal","year":"1988","journal-title":"Med. Clin. N. Am."},{"key":"10.1016\/j.schres.2021.01.006_bb0010","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1586\/ern.10.82","article-title":"Suicide in schizophrenia","volume":"10","author":"Carlborg","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.schres.2021.01.006_bb0015","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.4088\/JCP.13m08642","article-title":"Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics","volume":"74","author":"Citrome","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","article-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","volume":"1003","author":"Coyle","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2021.01.006_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2008.07.006","article-title":"Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study","volume":"105","author":"Daumit","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.01.006_bb0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/pds.1424","article-title":"Cardiovascular risks of atypical antipsychotic drug treatment","volume":"16","author":"Drici","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.schres.2021.01.006_bb0035","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/schbul\/sbt034","article-title":"Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?","volume":"39","author":"Harrow","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.01.006_bb0040","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.schres.2021.01.006_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1359786810385490","article-title":"Review: suicide and schizophrenia: a systematic review of rates and risk factors","volume":"24","author":"Hor","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2021.01.006_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.bp.111.104257","article-title":"Trends in prescriptions and costs of drugs for mental disorders in England, 1998\u20132010","volume":"200","author":"Ilyas","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0060","series-title":"Principles and Practice of Psychopharmacotherapy","author":"Janicak","year":"2010"},{"key":"10.1016\/j.schres.2021.01.006_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.eurpsy.2007.03.002","article-title":"A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study","volume":"22","author":"Kerwin","year":"2007","journal-title":"European Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jamapsychiatry.2013.149","article-title":"Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit\/hyperactivity disorder participating in psychopharmacology clinical trials","volume":"70","author":"Khan","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0075","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1017\/S0033291712000396","article-title":"Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia","volume":"42","author":"Lahti","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.01.006_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","article-title":"Excess early mortality in schizophrenia","volume":"10","author":"Laursen","year":"2014","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.schres.2021.01.006_bb0085","first-page":"309","article-title":"Korean society\u2019s perception toward suicide: \u201cus\u201d and \u201cthem\u201d represented in a TV documentary","volume":"35","author":"Lee","year":"2015","journal-title":"Korea Institute for health and social affairs"},{"key":"10.1016\/j.schres.2021.01.006_bb0090","first-page":"e15","article-title":"Cohort profile: the National Health Insurance Service\u2013National Sample Cohort (NHIS-NSC), South Korea","volume":"46","author":"Lee","year":"2017","journal-title":"Int. J. Epidemiol."},{"issue":"9831","key":"10.1016\/j.schres.2021.01.006_bb0200","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.schres.2021.01.006_bb0095","first-page":"1","article-title":"Schizophrenia\u2014an overview","author":"McCutcheon","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0100","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa1915784","article-title":"Association between mental disorders and subsequent medical conditions","volume":"382","author":"Momen","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2021.01.006_bb0105","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055176","article-title":"Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden","volume":"8","author":"Nordentoft","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2021.01.006_bb0115","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0120","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/YCO.0b013e32833f46c9","article-title":"Cardiovascular aspects of antipsychotics","volume":"23","author":"Raedler","year":"2010","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2021.01.006_bb0130","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archpsyc.1982.04290090071014","article-title":"Risk factors for suicide in psychiatric patients","volume":"39","author":"Roy","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.schres.2021.01.006_bb0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2215-0366(18)30177-9","article-title":"Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials","volume":"5","author":"Schneider-Thoma","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0145","first-page":"106","article-title":"Current situation and trends of suicidal deaths, ideas and attempts in Korea","volume":"21","author":"Seo","year":"2001","journal-title":"Korea Institute for health and social affairs"},{"key":"10.1016\/j.schres.2021.01.006_bb0150","first-page":"799","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea","volume":"46","author":"Seong","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.schres.2021.01.006_bb0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.schres.2017.12.010","article-title":"Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia","volume":"197","author":"Taipale","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.01.006_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2021.01.006_bb0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","article-title":"World psychiatric association Pharmacopsychiatry section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia","volume":"100","author":"Tandon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2021.01.006_bb0170","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2021.01.006_bb0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00002018-200528010-00003","article-title":"Atypical antipsychotics","volume":"28","author":"Titier","year":"2005","journal-title":"Drug-Safety"},{"key":"10.1016\/j.schres.2021.01.006_bb0180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/schbul\/sbu164","article-title":"Antipsychotic treatment and mortality in schizophrenia","volume":"41","author":"Torniainen","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2021.01.006_bb0185","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1017\/S0033291717000873","article-title":"Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis","volume":"47","author":"Vermeulen","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2021.01.006_bb0190","series-title":"Schizophrenia","author":"Warner","year":"1995"},{"key":"10.1016\/j.schres.2021.01.006_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.schres.2016.10.030","article-title":"Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis","volume":"182","author":"Wils","year":"2017","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:45:29Z","timestamp":1760298329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":40,"alternative-id":["S0920996421000487"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.01.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}